Dose Response Evaluation
- 1 July 1993
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 25 (1) , 1-5
- https://doi.org/10.2165/00003088-199325010-00001
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Aminoglutethimide in advanced breast cancer: plasma levels and clinical results after low and high dosesCancer Chemotherapy and Pharmacology, 1991
- Phase I clinical studies with cytotoxic drugs: pharmacokinetic and pharmacodynamic considerationsBritish Journal of Cancer, 1990
- Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- High dose versus low dose medroxyprogesterone acetate: a randomized trial in advanced breast cancerEuropean Journal of Cancer and Clinical Oncology, 1987
- Aminoglutethimide in advanced breast cancer: Clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/dayEuropean Journal of Cancer and Clinical Oncology, 1985
- Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer.1985
- Single-Dose and Steady-State Pharmacokinetics of AminoglutethimideClinical Pharmacokinetics, 1985